ENDPOINTS

Bioluminescence Ventures to shut down 15 months after launch

The life science investment firm Bioluminescence Ventures will close its doors less than two years after its founding, despite raising nearly half a billion dollars to put into new companies, Endpoints News has learned. ...

Feb 9, 2025 - 21:49
 0
Bioluminescence Ventures to shut down 15 months after launch
The life science investment firm Bioluminescence Ventures will close its doors less than two years after its founding, despite raising nearly half a billion dollars to put into new companies, Endpoints News has learned. ...
Read More

Tags:

Previous Article

Belgian regulator recommends blocking Indian drugmaker's API production

Next Article

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Related Posts

Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more

Q4 earnings updates; Biogen details revised research st...

Feb 9, 2025  0

Novo Nordisk takes aim at Roche in hemophilia A, but is way behind

Novo Nordisk takes aim at Roche in hemophilia A, but is...

Feb 9, 2025  0

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

Roivant discontinues lung disease drug; Bio-Thera, Inta...

Feb 10, 2025  0